A Randomised, Double-Blind, Placebo-Controlled, 2-Period Cross-Over Study to Evaluate the Effect of Treatment With GSK2190915 on the Allergen-Induced Asthmatic Response in Subjects With Mild Asthma.
Phase of Trial: Phase II
Latest Information Update: 01 Feb 2013
At a glance
- Drugs Fiboflapon (Primary)
- Indications Asthma
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 28 Sep 2011 Pharmacodynamic results assessing the effect of treatment on leukotriene levels presented at the 21st Annual Congress of the European Respiratory Society.
- 28 Sep 2011 Results presented at the 21st Annual Congress of the European Respiratory Society.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History